ICF-Based Effects of PNF and Kinesio Taping on Hand Function in Hemiplegic Stroke
Launched by ISTINYE UNIVERSITY · Jun 2, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how two different treatments—kinesio taping and PNF (Proprioceptive Neuromuscular Facilitation)—affect hand function in people who have hemiplegia due to a stroke. Hemiplegia means that one side of the body is weak or paralyzed. The researchers want to find out if these treatments help improve hand function and overall participation in daily activities. Participants will receive these treatments three times a week for eight weeks, with evaluations at the start and end of the study to assess any changes in hand function.
To be eligible for the study, participants must be at least 18 years old, have had a stroke diagnosed by MRI or CT, and have hemiplegia that has lasted for 6 to 24 months. They should also be able to cooperate with evaluations and speak Turkish. However, individuals with certain conditions, such as bilateral hemiplegia (weakness on both sides of the body) or major neurological disorders, will not be able to participate. This trial is a great opportunity for those who qualify to explore potential treatments that could help improve their hand function and quality of life following a stroke.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria:Inclusion criteria for the study (Junior et al., 2019; Kim \& Kim, 2015; Saklecha et al., 2023)
- • Stroke diagnosed by MRI or CT, regardless of ischemic or hemorrhagic origin,
- • Hemiplegia caused by stroke alone,
- • At least 6 and at most 24 months have passed since the stroke was diagnosed
- • Being over 18 years of age,
- • Volunteering to participate in the study
- • Scoring 24 or more on the Standardized Mini Mental State Examination (if illiterate, scoring 18 or more is sufficient)
- • Cooperating with evaluation, tests and treatment
- • Understanding and speaking Turkish
- • Being at least stage 4 according to Brunnstrom staging
- Exclusion Criteria:
- • Exclusion Criteria (Junior et al., 2019; Kim \& Kim, 2015; Saklecha et al., 2023)
- • Individuals with bilateral hemiplegia
- • Individuals with unstable vital signs
- • Individuals with any open wound in the upper extremity
- • Pathological conditions affecting upper extremity sensation (undergoing surgery after fracture, etc.)
- • Individuals with a BMI value greater than 29.9 kg/m2
- • Individuals with a Standardized Mini Mental Test score below 24 points (18 points)
- • Individuals with major neurological or rheumatological disorders affecting the musculoskeletal system other than stroke (Polyneuropathy, Parkinson's, Multiple Sclerosis, Rheumatoid Arthritis, etc.)
- • Presence of upper extremity amputation
- • Being at less than stage 4 according to Brunnstrom staging
About Istinye University
Istinye University is a leading academic institution committed to advancing medical research and education. With a strong emphasis on innovation and collaboration, the university actively engages in clinical trials that aim to enhance healthcare outcomes and contribute to scientific knowledge. Leveraging its state-of-the-art facilities and a team of experienced researchers and clinicians, Istinye University fosters a rigorous environment for conducting high-quality clinical studies across various medical disciplines. The institution is dedicated to ethical practices and patient safety, ensuring that all research initiatives align with the highest standards of integrity and scientific excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, Bahçeşir, Turkey
Samsun, Havza, Turkey
İstanbul, , Turkey
Patients applied
Trial Officials
Berrak Varhan
Study Director
Istinye University
Mahmut Yaran
Study Director
Ondokuz Mayıs University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported